Back to Results
First PageMeta Content
Pharmaceutical industry / Generic drug / Pharmaceuticals policy / Public domain / Food and Drug Administration / Abbreviated New Drug Application / Pliva / Pharmaceutical sciences / Pharmacology / Clinical research


Client Alert January 22, 2015 Generic Drug Manufacturers to Face Failure-toWarn Claims in California By Erin M. Bosman and Julie Y. Park On January 20, 2015, the Supreme Court declined to hear an appeal involving failure
Add to Reading List

Document Date: 2015-01-22 16:35:14

Open Document

File Size: 69,50 KB

Share Result on Facebook

Company

Wyeth Inc. / Buckman Co. / Teva / Morrison & Foerster LLP / PLIVA Inc. / USA Inc. / Wyeth LLC / /

Country

United States / /

/

Facility

California Court / Orange County Superior Court / COURT OF APPEAL’S OPINION The / /

IndustryTerm

brand-name manufacturer / generic pharmaceutical manufacturers / federal law / state-law failure-to-warn claims / state law tort principles / healthcare providers / drug manufacturer / generic manufacturer / /

MedicalCondition

drug-related injuries / injury / plaintiffs claiming injury / osteoporosis / injuries / /

Organization

Fulgenzi court / California Supreme Court / Orange County Superior Court / California Court of Appeal / Supreme Court / US Federal Reserve / California Court of Appeals / FDA / Pikerie court / first federal circuit court / /

Person

Erin M. Bosman / Julie Y. Park / Olga Pikerie / /

/

Position

Solicitor General / mofo.com Attorney / Lawyer / /

Product

Fosamax / Darvon / Darvocet / /

ProvinceOrState

California / /

PublishedMedium

The American Lawyer / /

URL

www.mofo.com / http /

SocialTag